Skip to content

The Effects of Wheat Sprouts Supplements on the Key Health Indicators of the Patients With Breast Cancer After Chemotherapy

The Effects of Wheat Sprouts Supplements on the Key Health Indicators of the Patients With Breast Cancer After Chemotherapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04998994
Enrollment
60
Registered
2021-08-10
Start date
2019-04-22
Completion date
2020-10-01
Last updated
2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional Status, Immune Function, Quality of Life Uring the Progress of Chemotherapy

Brief summary

To explore the effects of wheat sprouts supplements on the key health indicators of the patients with breast cancer after chemotherapy, Maiji tablets, a wheat sprouts supplement, were used to treat 26 patients during the progress of chemotherapy and nutritional status, immune function, quality of life were measured and evaluated. Through data analysis, we found that Maiji tablets may improve the symptoms of appetite loss, nausea and vomiting, and fatigue in patients with breast cancer during chemotherapy. Meanwhile it may help patients maintain weight, keep appetite and improve the food intake.

Interventions

DIETARY_SUPPLEMENTwheat sprouts supplement

Maiji tablets, a wheat sprouts supplement, were used to treat 26 patients during the progress of chemotherapy

Sponsors

First Affiliated Hospital of Wenzhou Medical University
CollaboratorOTHER
Quzhou Kecheng People's Hospital
CollaboratorUNKNOWN
Beijing Shijitan Hospital, Capital Medical University
CollaboratorOTHER
Jinhua Municipal Central Hospital
CollaboratorOTHER
Zhejiang Cancer Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\- patients diagnosed with breast cancer, receiving chemotherapy for the first time

Exclusion criteria

\- Patients with severe liver or kidney disease or other infectious diseases

Design outcomes

Primary

MeasureTime frameDescription
quality of life28 daysQuality of life was measured by quality of life assessment form
weight28 daysthe weight of patients
nutritional status28 daysnutritional status of patients

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026